EquitiesIndia.com

Healthcare · Drug Manufacturers - Specialty & Generic

Eris Lifesciences Ltd.

ERIS

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

Key metrics

Market Cap

₹19,000 cr

P/E Ratio

43.48x

P/B Ratio

6.66x

ROE

12.33%

ROCE

13.51%

Debt / Equity

0.87x

Net Margin

12.22%

Dividend Yield

97%

EPS

₹25.81

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 68.05%FII: 21.79%Public: 10.16%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Eris Lifesciences Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.